These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 20553023)

  • 1. Discovery of potent ligands for estrogen receptor beta by structure-based virtual screening.
    Shen J; Tan C; Zhang Y; Li X; Li W; Huang J; Shen X; Tang Y
    J Med Chem; 2010 Jul; 53(14):5361-5. PubMed ID: 20553023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New scaffolds for the design of selective estrogen receptor modulators.
    Martín-Santamaría S; Rodríguez JJ; de Pascual-Teresa S; Gordon S; Bengtsson M; Garrido-Laguna I; Rubio-Viqueira B; López-Casas PP; Hidalgo M; de Pascual-Teresa B; Ramos A
    Org Biomol Chem; 2008 Oct; 6(19):3486-96. PubMed ID: 19082149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and biochemical characterization of a series of 17α-perfluoroalkylated estradiols as selective ligands for estrogen receptor α.
    Eignerová B; Sedlák D; Dracínský M; Bartunek P; Kotora M
    J Med Chem; 2010 Oct; 53(19):6947-53. PubMed ID: 20812681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of natural estrogen receptor modulators with structure-based virtual screening.
    Cao X; Jiang J; Zhang S; Zhu L; Zou J; Diao Y; Xiao W; Shan L; Sun H; Zhang W; Huang J; Li H
    Bioorg Med Chem Lett; 2013 Jun; 23(11):3329-33. PubMed ID: 23608764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential response of estrogen receptor subtypes to 1,3-diarylindene and 2,3-diarylindene ligands.
    Clegg NJ; Paruthiyil S; Leitman DC; Scanlan TS
    J Med Chem; 2005 Sep; 48(19):5989-6003. PubMed ID: 16162002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective estrogen receptor modulators with conformationally restricted side chains. Synthesis and structure-activity relationship of ERalpha-selective tetrahydroisoquinoline ligands.
    Renaud J; Bischoff SF; Buhl T; Floersheim P; Fournier B; Geiser M; Halleux C; Kallen J; Keller H; Ramage P
    J Med Chem; 2005 Jan; 48(2):364-79. PubMed ID: 15658851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benzopyrans are selective estrogen receptor beta agonists with novel activity in models of benign prostatic hyperplasia.
    Norman BH; Dodge JA; Richardson TI; Borromeo PS; Lugar CW; Jones SA; Chen K; Wang Y; Durst GL; Barr RJ; Montrose-Rafizadeh C; Osborne HE; Amos RM; Guo S; Boodhoo A; Krishnan V
    J Med Chem; 2006 Oct; 49(21):6155-7. PubMed ID: 17034120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of ligand selectivity using reporter cell lines stably expressing estrogen receptor alpha or beta.
    Escande A; Pillon A; Servant N; Cravedi JP; Larrea F; Muhn P; Nicolas JC; Cavaillès V; Balaguer P
    Biochem Pharmacol; 2006 May; 71(10):1459-69. PubMed ID: 16554039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A selective estrogen receptor modulator designed for the treatment of uterine leiomyoma with unique tissue specificity for uterus and ovaries in rats.
    Hummel CW; Geiser AG; Bryant HU; Cohen IR; Dally RD; Fong KC; Frank SA; Hinklin R; Jones SA; Lewis G; McCann DJ; Rudmann DG; Shepherd TA; Tian H; Wallace OB; Wang M; Wang Y; Dodge JA
    J Med Chem; 2005 Nov; 48(22):6772-5. PubMed ID: 16250633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benzopyrans as selective estrogen receptor beta agonists (SERBAs). Part 2: structure-activity relationship studies on the benzopyran scaffold.
    Richardson TI; Norman BH; Lugar CW; Jones SA; Wang Y; Durbin JD; Krishnan V; Dodge JA
    Bioorg Med Chem Lett; 2007 Jul; 17(13):3570-4. PubMed ID: 17485205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery and structure-activity analysis of selective estrogen receptor modulators via similarity-based virtual screening.
    Shen J; Jiang J; Kuang G; Tan C; Liu G; Huang J; Tang Y
    Eur J Med Chem; 2012 Aug; 54():188-96. PubMed ID: 22647217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogen receptor ligands. II. Discovery of benzoxathiins as potent, selective estrogen receptor alpha modulators.
    Kim S; Wu JY; Birzin ET; Frisch K; Chan W; Pai LY; Yang YT; Mosley RT; Fitzgerald PM; Sharma N; Dahllund J; Thorsell AG; DiNinno F; Rohrer SP; Schaeffer JM; Hammond ML
    J Med Chem; 2004 Apr; 47(9):2171-5. PubMed ID: 15084115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigations on the effects of basic side chains on the hormonal profile of (4R,5S)/(4S,5R)-4,5-bis(4-hydroxyphenyl)-2-imidazolines.
    von Rauch M; Busch S; Gust R
    J Med Chem; 2005 Jan; 48(2):466-74. PubMed ID: 15658860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tetrahydroisoquinolines as subtype selective estrogen agonists/antagonists.
    Chesworth R; Zawistoski MP; Lefker BA; Cameron KO; Day RF; Mangano FM; Rosati RL; Colella S; Petersen DN; Brault A; Lu B; Pan LC; Perry P; Ng O; Castleberry TA; Owen TA; Brown TA; Thompson DD; DaSilva-Jardine P
    Bioorg Med Chem Lett; 2004 Jun; 14(11):2729-33. PubMed ID: 15125923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and evaluation of 17alpha-arylestradiols as ligands for estrogen receptor alpha and beta.
    Sedlák D; Novák P; Kotora M; Bartůnek P
    J Med Chem; 2010 May; 53(10):4290-4. PubMed ID: 20408532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Target specific virtual screening: optimization of an estrogen receptor screening platform.
    Knox AJ; Meegan MJ; Sobolev V; Frost D; Zisterer DM; Williams DC; Lloyd DG
    J Med Chem; 2007 Nov; 50(22):5301-10. PubMed ID: 17918820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of novel quinoline-based estrogen receptor ligands using peptide interaction profiling.
    Hoekstra WJ; Patel HS; Liang X; Blanc JB; Heyer DO; Willson TM; Iannone MA; Kadwell SH; Miller LA; Pearce KH; Simmons CA; Shearin J
    J Med Chem; 2005 Mar; 48(6):2243-7. PubMed ID: 15771467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen receptors: therapies targeted to receptor subtypes.
    Nilsson S; Gustafsson JÅ
    Clin Pharmacol Ther; 2011 Jan; 89(1):44-55. PubMed ID: 21124311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural evolutions of salicylaldoximes as selective agonists for estrogen receptor beta.
    Minutolo F; Bertini S; Granchi C; Marchitiello T; Prota G; Rapposelli S; Tuccinardi T; Martinelli A; Gunther JR; Carlson KE; Katzenellenbogen JA; Macchia M
    J Med Chem; 2009 Feb; 52(3):858-67. PubMed ID: 19128016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogen receptor beta selective ligands: discovery and SAR of novel heterocyclic ligands.
    Chesworth R; Wessel MD; Heyden L; Mangano FM; Zawistoski M; Gegnas L; Galluzzo D; Lefker B; Cameron KO; Tickner J; Lu B; Castleberry TA; Petersen DN; Brault A; Perry P; Ng O; Owen TA; Pan L; Ke HZ; Brown TA; Thompson DD; DaSilva-Jardine P
    Bioorg Med Chem Lett; 2005 Dec; 15(24):5562-6. PubMed ID: 16219463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.